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ABSTRACT: The direct and indirect costs of suspected human rabies exposure were estimated for
San Luis Obispo and Santa Barbara counties, California, USA. Clinic, hospital, and county public
health records (1998–2002) were examined to determine direct costs for postexposure prophylaxis
(PEP), and 55 (41%) former patients were contacted to voluntarily provide estimates of their
indirect costs associated with receiving PEP. Additional costs due to public health and animal
control personnel responses to rabid animals were collected, including diagnostic testing and
wages. The mean total cost of a suspected human rabies exposure was $3,688, the direct costs per
case were $2,564, and the indirect costs were $1,124 of that total. About one third of the total cost
for suspected human rabies exposure was attributed to indirect costs (e.g., lost wages,
transportation, and day-care fees), most of which were not reimbursable to the patient.
Key words: California, direct costs, economics, indirect costs, postexposure prophylaxis,
rabies.
INTRODUCTION
In 2004, 6,292 cases of wildlife rabies
were reported for the United States and
Puerto Rico (Krebs et al., 2005). Most of
these cases involved bats (Lasionycterus
spp., Myotis spp., and Pipstrellus spp.),
coyotes (Canis latrans), gray fox (Urocyon
cinereoargenteus), raccoons (Procylon lo-
tor), red fox (Vulpes vulpes), and skunks
(Mephitis spp. and Spirogola putorius)
(Krebs et al., 2005). Although the number
of human deaths due to rabies is low (the
median approximates three deaths per
year), the increased numbers of wildlife
rabies cases have coincided with increased
suspected human exposures (Childs,
2002).
The first confirmed case of domestic
canine rabies in California occurred in
1898; however, historical writings allude to
the disease in both animals and humans
more than 60 yr earlier (Humphrey,
1971). During the 1930s, domestic canine
rabies reached epidemic proportions
(.2,000 cases annually); these cases sub-
sided greatly (,25 cases annually) during
the 1950s after implementation of local
pet vaccination ordinances and a mandato-
ry statewide dog vaccination program for
counties declared ‘‘rabies endemic areas’’
during outbreaks (Humphrey, 1971).
Since the reduction of domestic canine
rabies during the 1950s, there has been
a marked increase in wildlife rabies cases.
Today, only bat and skunk variants of the
rabies virus are considered enzootic in
California (Crawford-Mitsza et al., 1999).
Human exposures to wildlife rabies
entail a variety of veterinary, medical,
legal, and insurance costs (Meltzer and
Rupprecht, 1998a). Human postexposure
prophylaxis (PEP) (made up of human
rabies immune globulin [HRIG] and
human diploid cell vaccine [HDCV]) and
pet vaccinations are probably the two
greatest factors determining the societal
cost of rabies (Meltzer, 1996). Few
empirical studies of the direct or indirect
costs associated with wildlife rabies have
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been reported, and none have quantified
the myriad of personal indirect costs
related to PEP that are incurred by
individuals (Uhaa et al., 1992; Kreindel
et al., 1998; Chang et al., 2002). Addition-
ally, most reported studies of the econom-
ics of rabies have been criticized for using
poorly documented data or inexact meth-
ods of defining costs (Meltzer and Rup-
precht, 1998b).
In the 1990s, it was reported that
between 16,000 and 39,000 persons re-
ceived PEP annually in the United States
(Krebs et al., 1998). Costs of PEP were
reported to range between $700 and
$5,000 (Uhaa et al., 1992; Kreindel et al.,
1998; Chang et al., 2002); however, the
price of PEP differs regionally due to the
cost of living, and along with other medical
services, increases regularly with inflation.
Periodic estimates of the monetary costs of
PEP are crucial to accurate economic
assessments aimed at detailing the finan-
cial burden of this disease.
This article presents results of an
archival and interview study to determine
direct and indirect costs associated with
human exposures to suspected rabid
wildlife in two southern California coun-
ties. The study involved a retrospective
approach, with follow-up interviews con-
ducted of patient volunteers that had
received PEP in San Luis Obispo (SLO)




Five years (from January 1998 to December
2002) of clinic, hospital, and public health
agency records in SLO and SB counties were
searched for cases of suspected human expo-
sure to rabid animals. All cases involving
administration of PEP were identified. Fol-
low-up telephone interviews were then con-
ducted with a sample of patient volunteers.
The study was approved by The Committee
for the Protection of Human Subjects, Cali-
fornia Department of Health Services (Sacra-
mento, California, USA).
Data forms
Three forms were prepared and used for
records retrieval and telephone interviews (see
Table 1 for a list of variables; the complete forms
are available in an online-only appendix at
United States Department of Agriculture (2005).
Form A (Local Public Health Costs) was
a 12-item list of Animal Rabies Case History
and a 20-item list of Costs to Local Govern-
ment. These data were recorded by research
staff by using clinic, hospital, and public health
records from the two counties. Rabies case
history data included incident information,
laboratory test results for the animal, numbers
of animals/humans exposed, circumstances
surrounding the human-animal contact, etc.
Form B (Direct Medical Costs for Rabies
PEP Treatment) was a seven-item list about
billing costs for PEP. This form was filled out
by researchers using records provided by the
clinics, medical facilities, and public health
offices. Form B was used to collect the direct
medical costs associated with each human
rabies exposure. These data included informa-
tion about the location and start of treatment;
method of payment; and direct costs required
to perform PEP, such as charges for HRIG,
HDCV, physician, and other charges.
Form C (Patient Interview) was a 53-item
questionnaire that provided uniformity for the
telephone interviews with each patient volun-
teer. These questions referred to the PEP and
other treatment-related costs borne by the
patient (e.g., lost wages, medicines for adverse
effects of treatment, travel time, day care, and
miscellaneous costs). Questions also attempted
to identify insurance copay or deductible
charges incurred by the patient (Table 1).
Procedures
Data collections occurred between April
and July 2003. Initially, clinics, hospitals, and
public health offices were visited by a re-
searcher who completed data entry for Forms
A and B on site. Each former patient was then
sent a postcard requesting participation in
a future interview. These individuals were told
that they would be contacted for a response
after 10 days. Patients that agreed to be
interviewed (patient volunteers) then sched-
uled a convenient date and time and partici-
pated in a ‘‘structured’’ telephone interview;
the interviewer sequentially read the questions
contained in Form C to the patient and
recorded the patient’s answers.
Data from Forms A, B, and C were
summarized using descriptive statistics; these
data characterized sample demographics and
rabies incidents. Cost estimates were comput-
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ed based on verified values among forms. We
converted all direct medical (PEP) cost and
computed all net present values for cited PEP
costs by using the medical component of the
Consumer Price Indexes (CPIs; United States
Department of Labor, 2005); all indirect cost
values were converted to 2004 US dollars
based on CPIs for urban consumers (Eco-
nomic Research, 2005).
Estimated case costs
Total cost (TC) per case of suspected
human exposure to rabies was estimated as
the sum of the direct costs (DC) and indirect
costs (IC) paid by patients, public heath
agencies, and county animal control units for
rabies-related charges (Fig. 1).
Estimates of TC and IC were derived using
the following formula where pep is cost of
PEP, med is other medical costs, ph is entailed
public health costs, ac is animal control costs, o
is other indirect costs, tt is travel time costs, lw
is lost wages, and alt is alternative medicines
for adverse reactions.
TC ~ pepz medð Þ
zfflfflfflfflfflfflfflfflffl}|fflfflfflfflfflfflfflfflffl{
DC
z phz acz oz ttz lwz altð Þ
zfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflffl}|fflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflffl{
IC
This equation was used to calculate average
DC and IC estimates as well as minimum and
maximum values. We used all DC and IC
mean charges to determine mean TC; mini-
mum and maximum values of specific charges
were then reported to provide estimates of
dispersion. The DC values were obtained from
Forms B and C, whereas IC values were
obtained exclusively from Form C responses.
All costs reported and verified for the patient
volunteers answering Form C were used in the
final IC cost computations. Therefore, IC
fiscal records for 32 of the 55 PEP patient
volunteers were verified and used; disparities,
missing data, or unknown costs for 23 patient
volunteers resulted in exclusion of their fiscal
data from only the IC portion of analysis.
Direct costs consisted of those costs associ-
ated with the provision and administration of
PEP and associated PEP charges. Because
rabies is monitored by public health agencies,
nonpatient costs referred to the initial physi-
cian’s diagnosis, subsequent administrations of
PEP, and the cost of the vaccines (HRIG plus
the five doses of HDCV). Direct patient costs
included insurance copayments or deductibles
plus any other specific medical charges di-
rectly paid by the patient for PEP.
Indirect costs were incurred by patient and
nonpatient (government) entities. Patient IC
referred to any lost wages, travel costs,
alternative medicine costs, or other outlays
related to the patient volunteer receiving PEP,
such as babysitter fees, day-care charges, long-
distance telephone costs, and psychological
TABLE 1. List of data entry categories and representative data items that made up records retrieval (Forms A
and B) and telephone interviews (Form C).
Form A: local public health costs
Form B: direct medical costs
for rabies PEP Form C: patient interviewa
Public health laboratory (e.g.,
relevant species, dates, case
facts about animal incident)
Type/location of medical facility Animal rabies exposure costs (e.g.,
specie, owner, exposure, injury,
residency, agency assistance)




Gender/age of patient Clinic or hospital visit costs (e.g.,
referral, physician visits, PEP
location, PEP regimen)
Laboratory costs (e.g., rabies
test, personnel exposure,
other)
Method of payments (e.g., self-pay,
insurance, worker’s compensation,
MediCare, other)
Treatment costs and lost wages
(e.g., payments, occupation,
income, missed work, lost wages)
Public health costs (e.g.,
employees and activities,
time, personnel exposure)
Direct medical costs (total) Adverse effects of PEP costs (e.g.,
reactions, visits for reactions, out-
of-pocket costs, missed work)
Veterinary costs (e.g., potential
veterinary involvement, time,
personnel exposure, other)
Details of PEP regimen and costs
(e.g., HRIG, vaccination series-
partials recorded, vaccination date)
Travel time and other costs (e.g.,
travel and mileage, babysitting
fees, other costs)
Other miscellaneous costs Other direct costs
a Interviews with patient volunteers (or parents/guardians) were ‘‘structured’’ (i.e., questions were posed in the same way
to all respondents).
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fees for counseling or anxiety treatment.
Nonpatient IC included public health and
animal control costs borne by county govern-
ments to contain the public health risk of the
disease. The average salary of public health
and animal control workers plus average
transportation and investigational costs (e.g.,
diagnostic laboratory test to identify the rabies
virus in animals) was used to value activities
based upon the mean hours worked/traveled
per case.
RESULTS
Patient demographics and rabies incidents
During the study period, 134 individu-
als in the two counties were involved in
suspected human exposures to rabies virus
and received PEP. Fifty-five (41%) of the
individuals contacted agreed to be study
volunteers and were interviewed. Several
reasons were cited for nonparticipation,
including individuals were not interested
or did not have the time to participate,
contact information was out dated and
individuals had changed their phone
number and mailing address, individuals
did not return phone calls (three messages
were left before giving up), and two
individuals had died. These patient volun-
teers consisted of 27 male (49%) and 28
female (51%) patients with a reported
mean age of 38 yr (range 0.6–77). Patient
volunteers reported a mean income cate-
gory of $30,001–$40,000 (range $20,001 to
.$70,001); two patients declined to pro-
vide income information.
The animals involved in suspected
exposures of the 55 patient volunteers
consisted of 12 (22%) dogs, eight (15%)
cats (Felis catus), 19 (35%) bats, four (7%)
skunks, three (5%) foxes, and nine (16%)
other species. Thirty-three (60%) and 14
(25%) incidents occurred within SLO and
SB counties, respectively. Interestingly,
eight (15%) rabies exposures occurred
outside these counties (respondents re-
turned to SLO and SB counties after
exposure, with PEP administered in the
respective county). Two suspected expo-
sures occurred in other counties of
California (Humbolt and Monterey), one
FIGURE 1. Average costs associated with rabies exposure. Estimates derived from 55 patients from San
Luis Obispo and Santa Barbara counties, California (1998–2002).
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exposure occurred in Texas, and five
exposures occurred in foreign countries
(two exposures in Mexico, two exposures
in Romania, and one exposure in the
Philippines). Thirty-nine (71%) patient
volunteers listed their residence as SLO
County and 15 (27%) listed their resi-
dence as SB County; one respondent gave
Washington state as the site of residency
at the time of the incident.
During the study period, 1,765 animals
were tested for rabies in SLO and SB
counties; they were predominantly domes-
tic pet and wildlife specimens with a few
livestock specimens. Skunk specimens
totaled 249 and 209 for SLO and SB
counties, with an average of 49.8 and 41.8
suspected rabid skunks tested each year,
respectively. Positive rabies tests were
obtained for 56 (22%) and 71 (34%) of
the skunks tested in SLO and SB counties,
respectively.
Case cost estimates
Mean TC of a suspected human rabies
exposure was $3,688 (range $721–$9,197)
(Fig. 1). Mean DC equaled $2,564 (range
$303–$6,455; 70% of TC) and IC equaled
$1,124 (range $418–$2,742; 30% of TC).
The mean nonpatient DC was $2,394
(range $293–$5,772), with one very low-
cost value possibly reflecting a partial
PEP. The patient DC mean was $170
(range $11–$682). Only 12% of those
interviewed stated that they paid the full
amount of the HRIG and HDCV treat-
ments; the remaining patients paid a small
portion through a copay or deductible.
Nonpatient IC (county public health
and animal control departments) had
a mean cost of $424 (range $259–$581)
per case; the mean cost of animal control
activities equaled $299 and accounted for
roughly two thirds of this cost. Mean
patient IC was $700 (range $161–$2,161).
The largest portion (69%) of these costs
was under the ‘‘other’’ category (mean
$485; range $16–$1,854), which included
day-care and babysitter costs associated
with parent respondents’ medical appoint-
ments for treatments or examinations.
Mean values for patients’ IC were travel
($12), lost wages ($144), and alternative
medicines ($59) paid by the patient made
up only 2, 21, and 8%, respectively. The
single highest reported cost was by one
patient who experienced severe adverse
reactions to the PEP and visited a psycho-
therapist due to mental anguish from
rabies exposure and treatment.
DISCUSSION
We conclude that indirect costs of
suspected human rabies exposures can
add one third to the direct costs common-
ly associated with these cases. Our find-
ings also confirm that suspected rabies
exposures exert sizable economic burdens
on local municipalities and county govern-
ments in rabies endemic areas.
Only three empirical studies have
sought to quantify rabies-related costs in
the United States (Uhaa et al., 1992;
Kreindel et al., 1998; Chang et al., 2002).
These studies dealt with economic data
from three eastern states where raccoon-
variant rabies epizootics occurred during
the 1980s and 1990s; the studies at-
tempted to quantify pre-epizootic and
epizootic shifts in rabies-related costs.
A study in New Jersey quantified
raccoon rabies-related costs in Hunterdon
and Warren counties by comparing 1988
costs (prerabies epizootic) with 1990 costs
(year of rabies epizootic) (Uhaa et al.,
1992). The study attempted to assess the
benefits of oral rabies vaccination and
incorporated some secondary costs associ-
ated with animal control (e.g., pet vaccina-
tions, bite investigations, public health
advertisements, and animal quarantines),
laboratory diagnosis (e.g., specimen prep-
aration and testing), and miscellaneous
other costs (e.g., education, training,
consultation, epidemiology, research, cler-
ical, and administrative). Total two-coun-
ty, municipal costs were estimated in 2004
US dollars at $1,743,351 versus $3,868,291
for 1988 and 1990, respectively. Exposures
SHWIFF ET AL.—DIRECT AND INDIRECT COSTS OF RABIES EXPOSURE 255
where PEP was administered increased
from two to 131 during these same years.
Interestingly, these authors assumed that
the indirect charges of lost time and
earnings of patients due to suspected
rabies exposures or to adverse reactions
from PEP were ‘‘minimal.’’
A study in Massachusetts examined
statewide reports of raccoon rabies be-
tween 1991 (pre-epizootic) and 1995 (soon
after start of the epizootic) to assess trends
in numbers of rabid raccoons; suspected
human exposures; and PEPs before,
during, and after the epizootic (Kreindel
et al., 1998). The incidence of PEPs
increased 26-fold between 1991 and
1995; this increase represented a jump
from approximately 1.7 to 45 PEPs per
100,000 residents. No estimates of the
indirect costs associated with this epizootic
were reported.
More recently, Chang et al. (2002)
reported extensive data on public health
impacts related to mainly raccoon-variant
rabies in New York state during the 1990s.
In total, 56,947 animal and 61 human
diagnostic tests for rabies were performed
between 1993 and 1998; these tests led to
18,238 PEP administrations during the
period. Roughly 16% of the animal speci-
mens tested positive for rabies throughout
the period, with positives peaking at 2,688
(23% of tests) in 1993 and declining to
1,097 (11% of tests) in 1998. Interestingly,
no decline in PEPs occurred, because
raccoons testing positive for rabies de-
clined during the period; PEPS remained
relatively high and stable. The average
PEP cost/patient ranged between $769
and $1,136 and increased in a transitive
manner across years of the study.
Our findings both agree and disagree
with certain aspects of studies by Uhaa et
al. (1992), Kreindel et al. (1998), and
Chang et al. (2002). Differences are
largely attributed to how specific cost
components were isolated in this and
previous studies for suspected rabies
exposures. Converting PEP-only direct
costs in the earlier studies to 2004 US
dollars yields a mean estimate of $2,292,
a cost relatively close to our $2,564 value,
and readily explained by our inclusion of
some ($170) patient DC (mean medical
costs borne directly by the patient).
Although the Kreindel et al. (1998) study
focused strictly on direct PEP costs, it did
not include indirect cost components;
thus, our total case charges differ. The
Uhaa et al. (1992) findings included both
direct and indirect estimates of patient
costs as well as the 1990 two-county costs
of $18,810 for bite investigations, $34,724
animal confinements, $248,378 general
rabies control salaries, and $36,035 animal
specimen preparation for rabies diagnos-
tics (17,572 specimens).
Economic uncertainty is associated with
determinations of disease-related costs in
assessing the potential savings from rabies
intervention activities. Uncertainty refers
to the variance of potential benefits and
costs likely to be derived from a myriad of
factors associated with these interventions
(e.g., animal population size, vaccination
efficacy, PEP costs, animal and control
costs). Reducing uncertainty by empirical
determinations of precise components of
the benefit-cost structure will allow public
health officials and other government
representatives to make more rational
fiscal policy decisions regarding control
of wildlife rabies. Our costs of human
rabies exposures did not capture all of the
potential costs associated with rabies; and
to date, such a study remains elusive. We
did not sample the money spent by
individuals who were not suspected of
being exposed to rabies but may have
dealt with possibly rabid animals, nor did
we include estimates of indirect expenses
needed to educate the public and public
health workers about the disease.
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